-+ 0.00%
-+ 0.00%
-+ 0.00%

Opmax announced that the company plans to purchase 100.00% of the shares of Pengli Biomedical Technology Co., Ltd. from 31 counterparties by issuing shares and paying cash at a transaction price of 1,451 billion yuan. At the same time, the company plans to raise no more than 35 specific investors, and the total amount raised will not exceed 100% of the transaction price of issuing shares to purchase assets.

Zhitongcaijing·12/31/2025 12:57:02
Listen to the news
Opmax announced that the company plans to purchase 100.00% of the shares of Pengli Biomedical Technology Co., Ltd. from 31 counterparties by issuing shares and paying cash at a transaction price of 1,451 billion yuan. At the same time, the company plans to raise no more than 35 specific investors, and the total amount raised will not exceed 100% of the transaction price of issuing shares to purchase assets.